Literature DB >> 19128871

Leptomeningeal dissemination of low-grade intramedullary gliomas: about one case and review.

Nicky D'Haene1, Nicolas Coen, Carine Neugroschl, Danielle Balériaux, Isabelle Salmon.   

Abstract

Leptomeningeal (LM) dissemination arises rarely in patients with low-grade gliomas. Few cases of LM dissemination of spinal cord low-grade gliomas have been reported in children. Here, we report a case of an intramedullary spinal cord low-grade glioma occurring in an adult presenting by LM dissemination. A 57-year-old man presented with a history of headaches and visual acuity deterioration. Neurological examination revealed mental confusion, decreasing left limb strength and left positive Babinski sign. Lumbar puncture showed low CSF glucose, high CSF protein and no tumor cells. Spinal MRI revealed an intramedullary spinal lesion with a diffuse leptomeningeal enhancement. A spinal meningeal biopsy showed arachnoiditis with isolated atypical cells which were cytokeratin immunopositive. A differential diagnosis was proposed between arachnoiditis close to an infectious process or close to meningeal carcinomatosis. An intramedullary biopsy was programmed but the patient died 1 month after biopsy. The post-mortem examination showed thickened leptomeninges and an ill-circumscribed intramedullary grey lesion. Histological examination revealed a low-grade glial neoplasm composed of monomorphous spindle "piloid" cells with diffuse dissemination to leptomeninges. Glial fibrillary acidic protein immunostaining showed scattered immunoreactive cells. Clinical and pathological features of this case are unusual. Pathogenesis and prognosis of low-grade gliomas with LM dissemination are poorly understood. This case, like cases occurring in children, cannot easily be classified in the present WHO system of classification of CNS tumors. Spinal low-grade gliomas with LM dissemination may represent a possible distinctive clinico-pathological entity.

Entities:  

Mesh:

Year:  2009        PMID: 19128871     DOI: 10.1016/j.clineuro.2008.11.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

Review 1.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

Review 2.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

3.  Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.

Authors:  P Gaviani; E Corsini; A Salmaggi; E Lamperti; A Botturi; A Erbetta; I Milanesi; F Legnani; B Pollo; A Silvani
Journal:  Neurol Sci       Date:  2013-03-24       Impact factor: 3.307

4.  Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.

Authors:  Maria Grazia Passarin; Giuseppe Moretto; Anna Maria Musso; Sarah Ottaviani; Barbara Masotto; Claudio Ghimenton; Paolo Iuzzolino; Ebba Buffone; Roberta Rudà; Riccardo Soffietti; Emanuela Vattemi; Rebecca Pedersini
Journal:  J Neurooncol       Date:  2009-10-31       Impact factor: 4.130

5.  Pineocytoma with diffuse dissemination to the leptomeninges.

Authors:  Caitlin Gomez; Jeffrey Wu; Whitney Pope; Harry Vinters; Antonio Desalles; Michael Selch
Journal:  Rare Tumors       Date:  2011-11-30

6.  A Retrospective Study on Spinal Dissemination of Supratentorial Glioma.

Authors:  Jianxin Chen; Fan Yang; Qi Shi; Yuze Zhao; Hongyan Huang
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.